Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification

This publication has 13 references indexed in Scilit:

• Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid
  New England Journal of Medicine, 1999
• Stratification of treatment of stage 4 neuroblastoma patients based on N-myc amplification status
  Medical and Pediatric Oncology, 1998
• Genetic Clinical Markers of Human Neuroblastoma with Special Reference to N-myc Oncogene: Amplified or Not Amplified? – An Overview
  Tumor Biology, 1996
• Treatment combined with bone marrow transplantation for advanced neuroblastoma: An analysis of patients who were pretreated intensively with the protocol of the study group of Japan
  Medical and Pediatric Oncology, 1995
• What is the benefit of aggressive chemotherapy for advanced neuroblastoma with N-myc amplification? A report from the Japanese study group for the treatment of advanced neuroblastoma
  Journal of Pediatric Surgery, 1994
• Improved survival rates in children over 1 year of age with stage III or IV neuroblastoma following an intensive chemotherapeutic regimen
  Journal of Pediatric Surgery, 1989
• Association of Multiple Copies of the N-mycOncogene with Rapid Progression of Neuroblastomas
  New England Journal of Medicine, 1985
• Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage
  Science, 1984
• Sequential cyclophosphamide and doxorubicin for induction of complete remission in children with disseminated neuroblastoma
  Cancer, 1981
• Clinical evaluation of sequentially scheduled cisplatin and vm26 in neuroblastoma: Response and toxicity
  Cancer, 1981